Xiaofeng Wan
Wuhu, 240001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Decoy Extracellular Vesicles Overcome Triple-Negative Breast Cancer Heterogeneity via Membrane-Cytoplasm-Mitochondria Cascade Targeting.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 10, 2025
Preventing liver carcinogenesis through the use of inhibitors targeting metabolic enzymes ACLY, G6PD, and TYMS, combined with 9-cis retinoic acid.
Journal: International journal of biological macromolecules
Published: December 02, 2024
Bioinformatics analysis and experimental validation of the oncogenic role of COL11A1 in pan-cancer.
Journal: 3 Biotech
Published: July 11, 2024
Construction of a prognostic model and analysis of related mechanisms in breast cancer based on multiple datasets.
Journal: Translational cancer research
Published: May 23, 2024
Dendritic polylysine co-delivery of paclitaxel and siAXL enhances the sensitivity of triple-negative breast cancer chemotherapy.
Journal: Frontiers in bioengineering and biotechnology
Published: April 10, 2024
WEE Family Kinase Inhibitors Combined with Sorafenib Can Selectively Inhibit HCC Cell Proliferation.
WEE Family Kinase Inhibitors Combined with Sorafenib Can Selectively Inhibit HCC Cell Proliferation.
Journal: Current cancer drug targets
Published: January 08, 2024
Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 01, 2024
The chemokine CCL20 can assist AFP in serological diagnosis of hepatocellular carcinoma.
Journal: Heliyon
Published: July 20, 2023
Pan-cancer analysis reveals the associations between MMP13 high expression and carcinogenesis and its value as a serum diagnostic marker.
Journal: Aging
Published: October 29, 2022
Nanopore-based metagenomic sequencing for the rapid and precise detection of pathogens among immunocompromised cancer patients with suspected infections.
Journal: Frontiers in cellular and infection microbiology
Published: May 14, 2022
RUNX1/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1.
RUNX1/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1.
Journal: Molecular therapy oncolytics
Published: April 18, 2021
AKT1-CREB stimulation of PDGFRα expression is pivotal for PTEN deficient tumor development.
Journal: Cell death & disease
Published: August 31, 2020
Last Updated: 09/26/2026